Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 3/20 | 0.63 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11854131 | 0.85 | TAS2R38 (0.61) | ALDH1A1HPGDEPHX1L3MBTL1LMNA | |
| SCHEMBL29522293 | 0.84 | L3MBTL1 (0.70) | ALDH1A1HPGDEPHX1NPC1RAB9A | |
| SCHEMBL1276741 | 0.84 | L3MBTL1 (0.70) | ALDH1A1HPGDEPHX1NPC1RAB9A | |
| SCHEMBL9060375 | 0.82 | NPC1 (0.59) | ALDH1A1HPGDEPHX1NPC1RAB9A | |
| SCHEMBL11125037 | 0.82 | HPGD (0.63) | ALDH1A1HPGDEPHX1NPC1RAB9A | |
| SCHEMBL8421703 | 0.80 | NPC1 (0.57) | ALDH1A1HPGDEPHX1NPC1RAB9A | |
| SCHEMBL194142 | 0.80 | ALDH1A1 (0.66) | ALDH1A1HPGDEPHX1NPC1RAB9A | |
| SCHEMBL29998429 | 0.80 | ALDH1A1 (0.66) | ALDH1A1HPGDEPHX1NPC1RAB9A | |
| SCHEMBL11310301 | 0.80 | NPC1 (0.57) | ALDH1A1HPGDEPHX1NPC1RAB9A | |
| SCHEMBL9725058 | 0.78 | ALDH1A1 (0.58) | ALDH1A1HPGDEPHX1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3154348-B1 | RODENTIA ANIMAL REPELLENT | SUMITOMO CHEMICAL CO (JP) | 2022-07-27 | — | — | EP | disclosed |
| WO-2022086079-A1 | DERIVATIVE OF SEMICARBAZONE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF | 고려대학교 산학협력단 | 2022-04-28 | — | — | WO | disclosed |
| US-10264789-B2 | Rodentia animal repellent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-04-23 | — | — | US | disclosed |
| US-10264789-B2 | Rodentia animal repellent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-04-23 | — | — | US | disclosed |
| US-20170118984-A1 | RODENTIA ANIMAL REPELLENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-04 | — | — | US | disclosed |
| US-20170118984-A1 | RODENTIA ANIMAL REPELLENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-04 | — | — | US | disclosed |
| US-20170118984-A1 | RODENTIA ANIMAL REPELLENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-04 | — | — | US | disclosed |
| EP-3154348-A1 | RODENTIA ANIMAL REPELLENT | Sumitomo Chemical Company, Limited (JP) | 2017-04-19 | — | — | EP | disclosed |
| US-9624211-B2 | Anti-cancer compounds | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-04-18 | — | — | US | disclosed |
| US-20160145250-A1 | ANTI-CANCER COMPOUNDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-05-26 | — | — | US | disclosed |
| WO-2015194676-A1 | RODENTIA ANIMAL REPELLENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-23 | — | — | WO | disclosed |
| EP-2444085-B1 | Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer | UNIV CALIFORNIA (US) | 2015-03-18 | — | — | EP | disclosed |
| EP-2420491-B1 | 3 , 5-SUBSTITUED PIPERIDINE COMPOUNDS AS RENIN INHIBITORS | NOVARTIS AG (CH) | 2013-07-03 | — | — | EP | disclosed |
| US-8143270-B2 | 2-amino 1H-in-imidazo ring systems and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143270-B2 | 2-amino 1H-in-imidazo ring systems and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-20110230419-A1 | IAP BINDING COMPOUNDS | NUEVOLUTION A/S (DK) | 2011-09-22 | — | — | US | disclosed |
| US-20090023720-A1 | 2-Amino 1H-Imidazo Ring Systems and Methods | 3M INNOVATIVE PROPERTIES COMPANY | 2009-01-22 | — | — | US | disclosed |
| US-20090023720-A1 | 2-Amino 1H-Imidazo Ring Systems and Methods | 3M INNOVATIVE PROPERTIES COMPANY | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10264789-B2 | Rodentia animal repellent | H1-4, HDAC11, HRH4 | ALDH1A1 667/4885HPGD 4196/4885EPHX1 912/4885 |
| US-20110230419-A1 | IAP BINDING COMPOUNDS | BIRC5, BIRC7, BIRC3 | ALDH1A1 2947/4885HPGD 2076/4885EPHX1 3900/4885 |
| US-20090023720-A1 | 2-Amino 1H-Imidazo Ring Systems and Methods | IL2, IL2RA, IL4I1 | ALDH1A1 1223/4885HPGD 437/4885EPHX1 2721/4885 |
| US-20160145250-A1 | ANTI-CANCER COMPOUNDS | SKP2, TP53, TEAD2 | ALDH1A1 353/4885HPGD 2692/4885EPHX1 3375/4885 |
| US-20170118984-A1 | RODENTIA ANIMAL REPELLENT | H1-4, HDAC11, HRH4 | ALDH1A1 667/4885HPGD 4196/4885EPHX1 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.